IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Clinical Investigation

• Publication date

  2011-10-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI44952PMID 21926464PMCID PMC3195455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

  2011cited by this paper
• Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models.

  2011cited by this paper
• Immunity, inflammation, and cancer.

  2010influential reference
• Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia

  2010cited by this paper
• Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.

  2010cited by this paper
• Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

  2010cited by this paper
• Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b

  2010cited by this paper
• Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer.

  2010cited by this paper
• Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.

  2010cited by this paper
• gp130 at the nexus of inflammation, autoimmunity, and cancer

  2010influential reference
• T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

  2009cited by this paper
• Thermal Facilitation of Lymphocyte Trafficking Involves Temporal Induction of Intravascular ICAM‐1

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

  2009cited by this paper
• Tumor self-seeding by circulating cancer cells.

  2009cited by this paper
• Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble–IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model

  2009cited by this paper
• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy

  2008cited by this paper
• Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.

  2008cited by this paper
• Adoptive cell transfer: a clinical path to effective cancer immunotherapy

  2008influential reference
• Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

  2008influential reference
• Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice.

  2008cited by this paper
• Vascular normalization in Rgs5-deficient tumours promotes immune destruction

  2008cited by this paper
• Radiation-Induced IFN-γ Production within the Tumor Microenvironment Influences Antitumor Immunity1

  2008influential reference
• Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells

  2008cited by this paper
• Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance.

  2007cited by this paper
• In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor

  2007cited by this paper
• Immunosuppressive strategies that are mediated by tumor cells.

  2007cited by this paper
• Significance of interleukin-6 (IL-6) in breast cancer (review)

  2007cited by this paper
• Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin

  2007cited by this paper
• T-Cell Distribution and Adhesion Receptor Expression in Metastatic Melanoma

  2007cited by this paper
• Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25− T Cells1

  2007cited by this paper
• Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion

  2006cited by this paper
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• Human T cell responses against melanoma.

  2006influential reference
• Interleukin-6 level in patients with colorectal cancer.

  2006cited by this paper
• Hurdles to Lymphocyte Trafficking in the Tumor Microenvironment: Implications for Effective Immunotherapy

  2006cited by this paper
• Random migration precedes stable target cell interactions of tumor-infiltrating T cells

  2006cited by this paper
• Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism

  2006cited by this paper
• Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

  2006cited by this paper
• Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation.

  2006cited by this paper
• Anti‐angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte‐endothelium interactions and infiltration in tumors

  2006cited by this paper
• The predictive value of CD8, CD4, CD68, and human leukocyte antigen‐D‐related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase

  2005cited by this paper
• Chemokines direct endothelial progenitors into tumor neovessels.

  2005cited by this paper
• An Important Role for Granulocytes in the Thermal Regulation of Colon Tumor Growth

  2005cited by this paper
• Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

  2005cited by this paper
• IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

  2005cited by this paper
• Randomized trial of hyperthermia and radiation for superficial tumors.

  2005cited by this paper
• TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

  2004cited by this paper
• Image processing with ImageJ

  2004cited by this paper
• The α vβ 3 integrin as a tumor homing ligand for lymphocytes

  2004cited by this paper
• TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

  2004cited by this paper
• Immune surveillance in the skin: mechanisms and clinical consequences

  2004influential reference
• Homing and cellular traffic in lymph nodes

  2003cited by this paper
• TGF‐β down‐regulates IL‐6 signaling in intestinal epithelial cells: Critical role of SMAD‐2

  2003cited by this paper
• Leukocyte recruitment in colon cancer: role of cell adhesion molecules, nitric oxide, and transforming growth factor beta1.

  2002cited by this paper
• A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models

  2002cited by this paper
• Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication.

  2002influential reference
• Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer

  2002cited by this paper
• The designer cytokine hyper-IL-6 mediates growth inhibition and GM–CSF-dependent rejection of B16 melanoma cells

  2001cited by this paper
• Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules.

  2001cited by this paper
• Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.

  2001cited by this paper
• Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature.

  2001cited by this paper
• Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo

  2000cited by this paper
• IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

  2000cited by this paper
• Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms1

  2000cited by this paper
• Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor.

  1999cited by this paper
• Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever‐like) whole body hyperthermia

  1998cited by this paper
• Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines.

  1998cited by this paper
• Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

  1997cited by this paper
• A bioactive designer cytokine for human hematopoietic progenitor cell expansion

  1997cited by this paper
• During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium.

  1996cited by this paper
• Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice.

  1996cited by this paper
• Distinct but overlapping epitopes are involved in alpha 4 beta 7-mediated adhesion to vascular cell adhesion molecule-1, mucosal addressin-1, fibronectin, and lymphocyte aggregation.

  1994cited by this paper
• Up‐regulation of the interleukin‐6‐signal transducing protein (gp130) by interleukin‐6 and dexamethasone in HepG2 cells

  1992cited by this paper
• Diminished leukocyte-endothelium interaction in tumor microvessels.

  1992cited by this paper
• Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes.

  1985cited by this paper

• Dual implication of endothelial adhesion molecules in tumor progression and cancer immunity

  2025cites this paper
• Sex parity in stimulation of murine lymphocyte trafficking in response to fever-range systemic thermal therapy

  2025influential citation
• Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer

  2025cites this paper
• C-reactive protein kinetics as prognostic biomarkers in advanced melanoma treated with immune checkpoint inhibitors.

  2025cites this paper
• Myosin II regulates cellular thermo-adaptability and the efficiency of immune responses.

  2025cites this paper
• Doxorubicin loaded polylactide nanoparticles functionalized histamine promote apoptosis of human gastric cancer cells AGS

  2025cites this paper
• From cold to hot: mechanisms of hyperthermia in modulating tumor immunology for enhanced immunotherapy

  2025cites this paper
• Functional Overview of Non-Neoplastic Cells in the Tumor Microenvironment

  2025cites this paper
• LAG‐3 : recent developments in combinational therapies in cancer

  2024cites this paper
• Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors

  2024cites this paper
• The antitumor activity of TGFβ-specific T cells is dependent on IL-6 signaling

  2024cites this paper
• Silencing PADI-2 induces antitumor effects by downregulating NF-κB, Nrf2/HO-1 and AKT1 in A549 lung cancer cells.

  2024cites this paper
• Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma.

  2024cites this paper
• Locoregional therapies combined with immune checkpoint inhibitors for liver metastases

  2024cites this paper
• Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment

  2024cites this paper
• Immunomodulatory and Anticancer Effects of Fridericia chica Extract-Loaded Nanocapsules in Myeloid Leukemia

  2024cites this paper
• M-MDSCs mediated trans-BBB drug delivery for suppression of glioblastoma recurrence post-standard treatment.

  2024cites this paper
• Mechanisms Underlying the Rarity of Skeletal Muscle Cancers

  2024cites this paper
• Deciphering the dual roles of PHD finger proteins from oncogenic drivers to tumor suppressors

  2024cites this paper
• PHF8/KDM7B: A Versatile Histone Demethylase and Epigenetic Modifier in Nervous System Disease and Cancers

  2024cites this paper
• Single-cell adhesive profiling in an optofluidic device elucidates CD8+ T lymphocyte phenotypes in inflamed vasculature-like microenvironments

  2024cites this paper
• Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy

  2024cites this paper
• Immune Cell Migration to Cancer

  2024cites this paper
• Cancer stem cell mimicry for immune evasion and therapeutic resistance.

  2024cites this paper
• Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions.

  2024cites this paper
• Subverting Attachment to Prevent Attacking: Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion

  2024influential citation
• The exercise IL-6 enigma in cancer.

  2023cites this paper
• Human intravital microscopy in the study of sarcomas: an early trial of feasibility

  2023cites this paper
• mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy

  2023cites this paper
• Pharmacological assessment of the antineoplastic and immunomodulatory properties of a new spiroindolone derivative (7’,8’-Dimethoxy-1’,3’-dimethyl-1,2,3’,4’-tetrahydrospiro[indole-3,5’-pyrazolo[3,4-c]isoquinolin]-2-one) in chronic myeloid leukemia

  2023cites this paper
• Albendazole induces an anti-tumor effect and potentiates PD-L1 blockade immunotherapy

  2023cites this paper
• Prognostic and Immune Infiltration Signatures of GIMAP Family Genes in Clear Cell Renal Cell Carcinoma.

  2023cites this paper
• Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression

  2023cites this paper
• AI-2 quorum sensing controlled delivery of cytolysin-A by tryptophan auxotrophic low-endotoxic Salmonella and its anticancer effects in CT26 mice with colon cancer

  2023cites this paper
• PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies

  2023cites this paper
• Adhesion analysis via a tumor vasculature-like microfluidic device identifies CD8+ T cells with enhanced tumor homing to improve cell therapy

  2023cites this paper
• Cytotoxic and immunomodulatory potential of a novel [2-(4-(2,5-dimethyl-1H-pyrrol-1-yl)-1H-pyrazol-3-yl)pyridine] in myeloid leukemia.

  2023cites this paper
• Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin

  2023cites this paper
• Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside.

  2022cites this paper
• Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications

  2022influential citation
• Extracellular Vesicles Derived from Acidified Metastatic Melanoma Cells Stimulate Growth, Migration, and Stemness of Normal Keratinocytes

  2022cites this paper
• Perspectives on Vascular Regulation of Mechanisms Controlling Selective Immune Cell Function in the Tumor Immune Response

  2022cites this paper
• Adhesion molecules in multiple myeloma oncogenesis and targeted therapy

  2022cites this paper
• Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines

  2022cites this paper
• STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular Carcinoma

  2022cites this paper
• Tumor necrosis factor receptor regulation of peripheral node addressin biosynthetic components in tumor endothelial cells

  2022cites this paper
• Circadian rhythms and cancers: the intrinsic links and therapeutic potentials

  2022cites this paper
• Carboplatin enhances lymphocyte-endothelial interactions to promote CD8+ T cell trafficking into the ovarian tumor microenvironment.

  2022cites this paper
• Cancer resistance to immunotherapy: What is the role of cancer stem cells?

  2022cites this paper
• NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation

  2022cites this paper
• Manipulating adrenergic stress receptor signalling to enhance immunosuppression and prolong survival of vascularized composite tissue transplants

  2022cites this paper
• Biological modeling in thermoradiotherapy: present status and ongoing developments toward routine clinical use

  2022cites this paper
• A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer

  2022cites this paper
• Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives

  2022cites this paper
• The Therapeutic Role of PNU-74654 in Hepatocellular Carcinoma May Involve Suppression of NF-κB Signaling

  2022cites this paper
• Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis

  2022cites this paper
• Effects of infection-induced fever and the interaction with interleukin-6 rs1800796 polymorphism on the prognosis of breast cancer.

  2022cites this paper
• Nanotechnology Tools Enabling Biological Discovery.

  2022cites this paper
• Biological characteristics of IL-6 and related intestinal diseases

  2021cites this paper
• A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer

  2021cites this paper
• The spatio-temporal control of effector T cell migration

  2021cites this paper
• Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles.

  2021cites this paper
• Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence

  2021cites this paper
• The calcium-binding protein S100B reduces IL6 production in malignant melanoma via inhibition of RSK cellular signaling

  2021cites this paper
• Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment

  2021cites this paper
• Impact of C-reactive Protein Flare Response in Patients With Advanced Urothelial Carcinoma Who Received Pembrolizumab

  2021cites this paper
• Whole-body hyperthermia combined with chemotherapy and intensity-modulated radiotherapy for treatment of advanced nasopharyngeal carcinoma: a retrospective study with propensity score matching

  2021cites this paper
• Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies

  2021cites this paper
• Interleukin-6 Trans-signaling: A Pathway With Therapeutic Potential for Diabetic Retinopathy

  2021cites this paper
• Temperature Plays an Essential Regulatory Role in the Tumor Immune Microenvironment.

  2021cites this paper
• Exercise-induced myokines and their effect on prostate cancer

  2021cites this paper
• Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

  2021cites this paper
• A pilot trial of intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosis

  2021cites this paper
• On the Possibility of a Microwave Approach for Rooms and Objects Sterilization

  2021cites this paper
• Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation.

  2021cites this paper
• An innovative high frequency hyperthermia approach against SARS-CoV-2 and related virus: feasibility analysis

  2021cites this paper
• Immunological Consequences of Nanoparticle‐Mediated Antitumor Photoimmunotherapy

  2020cites this paper
• Glycans as Targets and Mediators of T-Cell Immunotherapy

  2020cites this paper
• IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy.

  2020cites this paper
• Cytokine and Chemokine Signals of T-Cell Exclusion in Tumors

  2020cites this paper
• Combination Therapy of Pulsed-Wave Ultrasound Hyperthermia and Immunostimulant OK-432 Enhances Systemic Antitumor Immunity for Cancer Treatment.

  2020cites this paper
• Mesenchymal stem/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression

  2020cites this paper
• Targeted Antitumor Mechanism of C-PC/CMC-CD55sp Nanospheres in HeLa Cervical Cancer Cells

  2020cites this paper
• Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance

  2020cites this paper
• IL-6 Blockade Limitations as an Anticancer Strategy: Literature Review and Proposal of Explanations for Unexpected Results

  2020cites this paper
• A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy

  2020cites this paper
• Molecular and biological rationale of hyperthermia as radio- and chemosensitizer.

  2020cites this paper
• Resident Memory T Cells in the Tumor Microenvironment.

  2020cites this paper
• Protocol Title

  2020cites this paper
• Hyperthermia Targeting the Tumor Microenvironment Facilitates Immune Checkpoint Inhibitors

  2020cites this paper
• Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma

  2020cites this paper
• Hyperthermic intraperitoneal chemotherapy (HIPEC): Should we look closer at the microenvironment?

  2020cites this paper
• Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels

  2020cites this paper
• IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells

  2020cites this paper
• Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

  2020cites this paper
• Tumor Microenvironment: Hematopoietic Cells – Part B

  2020cites this paper
• Moderate physical exercise improves lymphocyte function in melanoma-bearing mice on a high-fat diet

  2019cites this paper
• Intravital Microscopy (IVM) in Human Solid Tumors: Novel Protocol to Examine Tumor-Associated Vessels

  2019cites this paper
• Activation of human vascular endothelium in melanoma metastases induces ICAM‐1 and E‐selectin expression and results in increased infiltration with effector lymphocytes

  2019cites this paper
• Inhibition of Tyrosine-Phosphorylated STAT3 in Human Breast and Lung Cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 Receptor

  2019cites this paper